These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 14626231

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Medicine goes Madison Avenue: an evaluation of the effect of direct-to-consumer pharmaceutical advertising on the learned intermediary doctrine.
    Allen MC.
    Spec Law Dig Health Care Law; 1998 Dec; (236):9-29. PubMed ID: 10187553
    [No Abstract] [Full Text] [Related]

  • 3. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
    Berndt ER.
    N Engl J Med; 2005 Jan 27; 352(4):325-8. PubMed ID: 15673797
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The FDA's restrictions against prescription drug advertising: more hindrance than help.
    Lorman AJ.
    Healthspan; 1991 Nov 27; 8(10):3-7. PubMed ID: 10114942
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Drug safety special: chasing shadows.
    Frantz S.
    Nature; 2005 Mar 31; 434(7033):557-8. PubMed ID: 15800592
    [No Abstract] [Full Text] [Related]

  • 11. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL, Katz KA.
    Br J Dermatol; 2006 May 31; 154(5):950-8. PubMed ID: 16634900
    [Abstract] [Full Text] [Related]

  • 12. Prescription for trouble: common drugs, hidden dangers. Tens of people are at risk.
    Consum Rep; 2006 Jan 31; 71(1):34-9. PubMed ID: 16491527
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA.
    Issue Brief Health Policy Track Serv; 2009 Jan 05; ():1-28. PubMed ID: 19297718
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The promise and peril of direct-to-consumer prescription drug promotion on the Internet.
    Hall TS.
    DePaul J Health Care Law; 2003 Jan 05; 7(1):1-41. PubMed ID: 15468476
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK, Swartz L.
    Arch Intern Med; 2005 Jun 27; 165(12):1363-9. PubMed ID: 15983284
    [Abstract] [Full Text] [Related]

  • 19. Processing and evaluation of adverse drug experience reports at the Food and Drug Administration Center for Veterinary Medicine.
    Keller WC, Bataller N, Oeller DS.
    J Am Vet Med Assoc; 1998 Jul 15; 213(2):208-11. PubMed ID: 9676589
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.